Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $12.0800 (-0.25%) ($12.0800 - $12.0800) on Tue. Jul. 11, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.31% (three month average) | RSI | 33 | Latest Price | $12.0800(-0.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -0.3% a day on average for past five trading days. | Weekly Trend | FOLD declines -2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(62%) IBB(58%) ARKG(51%) IWO(41%) BWX(40%) | Factors Impacting FOLD price | FOLD will decline at least -1.155% in a week (0% probabilities). TBT(-35%) EDOC(-25%) UUP(-16%) VXX(-9%) VIXM(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.155% (StdDev 2.31%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $6.31(-47.76%) | Resistance Level | $12.49 | 5 Day Moving Average | $12.08(0%) | 10 Day Moving Average | $12.24(-1.31%) | 20 Day Moving Average | $12.49(-3.28%) | To recent high | -8.3% | To recent low | 12.4% | Market Cap | $3.119b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |